Larvol Delta - IZAR1-Evaluation-of-Sonelokimab-in-Patients-With-Active-Psoriatic-Arthritis-Naive-to-Biologic-DiseaseModifying-Antirheumatic-Drug

sonelokimab (M1095) - Avillion, MoonLake Immunotherap

http://clinicaltrials.gov/ct2/show/NCT06641076

Feb 25, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next